PNPLA3 and metabolic syndrome: No significant differences were found in terms of the PNPLA3 genotype regarding the degree of subclinical atherosclerosis, the presenceor the components of the metabolic syndrome, or HOMA-IR index (Table 7 and Supplementary Table S4).